Waste Management
Compare Stocks
4 / 10Stock Comparison
CDTG vs ECVT vs PESI vs GEVO
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Waste Management
Chemicals - Specialty
CDTG vs ECVT vs PESI vs GEVO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Waste Management | Chemicals - Specialty | Waste Management | Chemicals - Specialty |
| Market Cap | $3M | $1.53B | $207M | $493M |
| Revenue (TTM) | $36M | $819M | $59M | $174M |
| Net Income (TTM) | $7M | $-63M | $-18M | $-11M |
| Gross Margin | 35.2% | 22.6% | 4.1% | 23.4% |
| Operating Margin | 23.5% | 15.4% | -26.3% | -4.6% |
| Forward P/E | 2.0x | 22.9x | — | — |
| Total Debt | $6M | $431M | $4M | $168M |
| Cash & Equiv. | $124K | $197M | $12M | $1M |
CDTG vs ECVT vs PESI vs GEVO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 24 | May 26 | Return |
|---|---|---|---|
| CDT Environmental T… (CDTG) | 100 | 8.1 | -91.9% |
| Ecovyst Inc. (ECVT) | 100 | 148.1 | +48.1% |
| Perma-Fix Environme… (PESI) | 100 | 97.6 | -2.4% |
| Gevo, Inc. (GEVO) | 100 | 308.1 | +208.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDTG vs ECVT vs PESI vs GEVO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CDTG carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 0.34, Low D/E 15.1%, current ratio 1.50x
- Better valuation composite
- 19.8% margin vs PESI's -30.1%
- Beta 0.34 vs PESI's 1.85
ECVT is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 2 yrs, beta 0.90
- Beta 0.90, current ratio 2.64x
- +102.7% vs CDTG's -61.7%
PESI is the clearest fit if your priority is long-term compounding.
- 178.6% 10Y total return vs ECVT's 9.9%
GEVO is the clearest fit if your priority is growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs CDTG's -13.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs CDTG's -13.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 19.8% margin vs PESI's -30.1% | |
| Stability / Safety | Beta 0.34 vs PESI's 1.85 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +102.7% vs CDTG's -61.7% | |
| Efficiency (ROA) | 8.0% ROA vs PESI's -20.2%, ROIC 3.6% vs -21.7% |
CDTG vs ECVT vs PESI vs GEVO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CDTG vs ECVT vs PESI vs GEVO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ECVT leads in 2 of 6 categories
CDTG leads 2 • PESI leads 0 • GEVO leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ECVT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ECVT is the larger business by revenue, generating $819M annually — 22.7x CDTG's $36M. CDTG is the more profitable business, keeping 19.8% of every revenue dollar as net income compared to PESI's -30.1%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $36M | $819M | $59M | $174M |
| EBITDAEarnings before interest/tax | $9M | $136M | -$14M | $18M |
| Net IncomeAfter-tax profit | $7M | -$63M | -$18M | -$11M |
| Free Cash FlowCash after capex | -$3M | $84M | -$14M | -$35M |
| Gross MarginGross profit ÷ Revenue | +35.2% | +22.6% | +4.1% | +23.4% |
| Operating MarginEBIT ÷ Revenue | +23.5% | +15.4% | -26.3% | -4.6% |
| Net MarginNet income ÷ Revenue | +19.8% | -7.7% | -30.1% | -6.6% |
| FCF MarginFCF ÷ Revenue | -8.8% | +10.2% | -23.4% | -19.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -87.3% | +32.6% | -20.1% | +47.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | +2.3% | -110.5% | +3.8% |
Valuation Metrics
CDTG leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, CDTG's 3.6x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3M | $1.5B | $207M | $493M |
| Enterprise ValueMkt cap + debt − cash | $9M | $1.8B | $200M | $659M |
| Trailing P/EPrice ÷ TTM EPS | 1.99x | -22.90x | -14.89x | -14.50x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.87x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 3.65x | 13.28x | — | 102.12x |
| Price / SalesMarket cap ÷ Revenue | 0.10x | 2.11x | 3.36x | 3.07x |
| Price / BookPrice ÷ Book value/share | 0.08x | 2.68x | 4.11x | 1.01x |
| Price / FCFMarket cap ÷ FCF | — | 21.87x | — | — |
Profitability & Efficiency
CDTG leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CDTG delivers a 19.1% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-34 for PESI. PESI carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to ECVT's 0.71x. On the Piotroski fundamental quality scale (0–9), ECVT scores 6/9 vs GEVO's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.1% | -10.2% | -34.5% | -2.4% |
| ROA (TTM)Return on assets | +8.0% | -4.2% | -20.2% | -1.7% |
| ROICReturn on invested capital | +3.6% | +4.2% | -21.7% | -2.8% |
| ROCEReturn on capital employed | +5.7% | +4.6% | -16.7% | -3.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.15x | 0.71x | 0.09x | 0.36x |
| Net DebtTotal debt minus cash | $6M | $234M | -$7M | $166M |
| Cash & Equiv.Liquid assets | $124,379 | $197M | $12M | $1M |
| Total DebtShort + long-term debt | $6M | $431M | $4M | $168M |
| Interest CoverageEBIT ÷ Interest expense | 52.81x | 2.08x | -42.14x | -0.04x |
Total Returns (Dividends Reinvested)
Evenly matched — ECVT and PESI and GEVO each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PESI five years ago would be worth $14,563 today (with dividends reinvested), compared to $844 for CDTG. Over the past 12 months, ECVT leads with a +102.7% total return vs CDTG's -61.7%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs CDTG's -56.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.9% | +40.9% | -8.8% | -1.5% |
| 1-Year ReturnPast 12 months | -61.7% | +102.7% | +26.2% | +88.0% |
| 3-Year ReturnCumulative with dividends | -91.6% | +32.9% | +21.7% | +65.0% |
| 5-Year ReturnCumulative with dividends | -91.6% | +15.4% | +45.6% | -65.2% |
| 10-Year ReturnCumulative with dividends | -91.6% | +9.9% | +178.6% | -98.6% |
| CAGR (3Y)Annualised 3-year return | -56.1% | +9.9% | +6.8% | +18.2% |
Risk & Volatility
Evenly matched — CDTG and ECVT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CDTG is the less volatile stock with a 0.34 beta — it tends to amplify market swings less than PESI's 1.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ECVT currently trades 93.5% from its 52-week high vs CDTG's 13.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.34x | 0.90x | 1.85x | 1.64x |
| 52-Week HighHighest price in past year | $2.13 | $14.94 | $16.50 | $2.97 |
| 52-Week LowLowest price in past year | $0.21 | $6.69 | $8.02 | $1.01 |
| % of 52W HighCurrent price vs 52-week peak | +13.1% | +93.5% | +67.7% | +68.4% |
| RSI (14)Momentum oscillator 0–100 | 38.0 | 66.9 | 41.5 | 53.5 |
| Avg Volume (50D)Average daily shares traded | 619K | 2.2M | 164K | 4.5M |
Analyst Outlook
ECVT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ECVT as "Buy", PESI as "Hold", GEVO as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -30.8% for ECVT (target: $10).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $9.67 | $18.00 | $3.50 |
| # AnalystsCovering analysts | — | 6 | 1 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 2 | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +19.9% | +3.1% | 0.0% | 0.0% |
ECVT leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). CDTG leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
CDTG vs ECVT vs PESI vs GEVO: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is CDTG or ECVT or PESI or GEVO a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -13. 0% for CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG). CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG) offers the better valuation at 2. 0x trailing P/E, making it the more compelling value choice. Analysts rate Ecovyst Inc. (ECVT) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CDTG or ECVT or PESI or GEVO?
Over the past 5 years, Perma-Fix Environmental Services, Inc.
(PESI) delivered a total return of +45. 6%, compared to -91. 6% for CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG). Over 10 years, the gap is even starker: PESI returned +178. 6% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CDTG or ECVT or PESI or GEVO?
By beta (market sensitivity over 5 years), CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG) is the lower-risk stock at 0.
34β versus Perma-Fix Environmental Services, Inc. 's 1. 85β — meaning PESI is approximately 435% more volatile than CDTG relative to the S&P 500. On balance sheet safety, Perma-Fix Environmental Services, Inc. (PESI) carries a lower debt/equity ratio of 9% versus 71% for Ecovyst Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — CDTG or ECVT or PESI or GEVO?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -13. 0% for CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -916. 7% for Ecovyst Inc.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CDTG or ECVT or PESI or GEVO?
CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG) is the more profitable company, earning 4.
9% net margin versus -22. 3% for Perma-Fix Environmental Services, Inc. — meaning it keeps 4. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ECVT leads at 9. 0% versus -19. 0% for PESI. At the gross margin level — before operating expenses — CDTG leads at 37. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CDTG or ECVT or PESI or GEVO more undervalued right now?
Analyst consensus price targets imply the most upside for GEVO: 72.
4% to $3. 50.
07Which pays a better dividend — CDTG or ECVT or PESI or GEVO?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is CDTG or ECVT or PESI or GEVO better for a retirement portfolio?
For long-horizon retirement investors, CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
34)). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CDTG: -91. 6%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CDTG and ECVT and PESI and GEVO?
These companies operate in different sectors (CDTG (Industrials) and ECVT (Basic Materials) and PESI (Industrials) and GEVO (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CDTG is a small-cap deep-value stock; ECVT is a small-cap quality compounder stock; PESI is a small-cap quality compounder stock; GEVO is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.